Informationen:
Fehler:
Stichworte
Lost to Follow-Up ×
- End of Study (11)
- Klinische Studie [Dokumenttyp] (8)
- Verlaufsstudien (8)
- Hepatitis-B-Vakzine (6)
- Klinische Studie, Phase II [Dokumenttyp] (6)
- Menigokokkenvakzine (6)
- Hepatitis A-Vakzine (5)
- Klinische Studie, Phase III [Dokumenttyp] (3)
- Adverse event (3)
- Forschungspersonal (2)
- Asthma (2)
- Protocol Deviation (2)
- Testosteron (1)
- Endometriumtumoren (1)
- Behandlungsfehler (1)
- Malariavakzinen (1)
- Haemophilus influenzae Typ b (1)
- Topotecan (1)
- Diphtherie-Tetanus-azelluläre-Pertussis-Vakzine (1)
- Karzinom (1)
- Leukämie, Juvenile myelomonozytische (1)
- Infektionskrankheit, Medizin (1)
- Arzneimittelbezogene Randeffekte und Nebenwirkungen (1)
- Drug trial (1)
- Cisplatin (1)
- Hypogonadismus (1)
- Einverständniserklärung (1)
- Malaria (1)
- Myelodysplastische Syndrome (1)
- Tumoren (1)
- Neurologie (1)
- Parkinson-Krankheit (1)
- Patientenbeteiligung (1)
Inhaltsverzeichnis
Ausgewählte Datenmodelle
Sie müssen eingeloggt sein, um mehrere Datenmodelle auszuwählen und diese herunterzuladen oder zu analysieren.
21 Suchergebnisse.
Itemgruppen: Informed consent, Demographics, Laboratory Tests, Follow-up studies, Investigator signature, Tracking Document Reason for non participation
Itemgruppen: Informed consent, Demographics, Laboratory Tests, Follow-up studies, Investigator signature, Tracking Document Reason for non participation
Itemgruppen: Informed consent, Demographics, Laboratory Tests, Follow-up studies, Investigator signature, Tracking Document Reason for non participation
Itemgruppen: Informed consent, Demographics, Laboratory Tests, Follow-up studies, Occurrence of serious adverse event, Investigator signature, Tracking Document Reason for non participation
Itemgruppen: Informed consent, Demographics, Laboratory Tests, Follow-up studies, Investigator signature, Tracking Document Reason for non participation
Itemgruppen: Administrative data, Reason for non participation, Investigator's Signature
Itemgruppen: Administrative data, Treatment Completion, Tumor Measurements, Best Tumor Response, Follow-Up Form, Disease Follow-Up Status, Notice of New Primary, Long Term Adverse Events, Adverse Events details, Additional Cancer Therapy
Itemgruppen: Administrative data, Reason for Non-Participation, Investigator's Signature
Itemgruppen: Study conclusion details, If YES, complete primary reason for withdrawal
Itemgruppe: Run-In Failure
Itemgruppen: Administrative documentation, Clinical Research, Conclusion
Itemgruppe: Study Conclusion